ASH 2023: New drug helps narrow racial survival disparity in patients with acute myeloid leukaemia
Non-Hispanic Black patients with acute myeloid leukaemia (AML) are living longer, now that new therapies are available,…
Browsing: AML
Leukaemia cells activate cellular recycling program
In a recent study, scientists led by Professor Stefan Müller from Goethe University’s Institute of…
Dietary selenium may help combat myeloid leukaemia, mouse study suggests
Selenium-enriched diets may help ward off myeloid leukaemia, and a new study led by researchers…
Patients with AML who received vitamin C/D supplements had fewer complications, but no OS benefit seen
Patients with acute myeloid leukaemia (AML) who received vitamin C and D supplements while undergoing…
FDA approves quizartinib for newly diagnosed acute myeloid leukaemia
On July 20, 2023, the Food and Drug Administration approved quizartinib with standard cytarabine and…
Differentiation landscape of acute myeloid leukaemia charted with new tool
Researchers have developed a new method to distinguish between cancerous and healthy stem cells and…
AACR 2023: Scientists create powerful, most-accurate tools to research deadliest blood cancer, study says
Tisch Cancer Center scientists developed unique models of the deadliest blood cancer, acute myeloid leukaemia…
UNSW researchers receive more than $5.9m in Cancer Institute NSW grants
Professor John Pimanda receives the new Translational Program Grant for his team’s work with acute myeloid…
Inflammation levels tied to severity of blood cancer
Severe inflammation weakens the body’s ability to kill cancerous blood cells in people with acute…
Joining forces with nature for new cancer therapies
Natural compounds often have promising therapeutic potential but their use to treat diseases is hampered…